In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention
Bagai A, Wang Y, Wang TY, Curtis JP, Gurm HS, Shah B, Cheema AN, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL, Alexander KP. In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention. Circulation Cardiovascular Interventions 2014, 7: 585-593. PMID: 25097196, DOI: 10.1161/circinterventions.114.001555.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAge FactorsAgedClopidogrelDrug SubstitutionFemaleHumansMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPiperazinesPostoperative ComplicationsPractice Guidelines as TopicPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsRecurrenceRegistriesRisk FactorsThiophenesThrombosisTiclopidineUnited StatesConceptsPercutaneous coronary interventionMyocardial infarctionCoronary interventionHospital coronary artery bypassIntervention Outcomes Network RegistryStudy periodAcute Coronary TreatmentHierarchical logistic regression modelingCoronary artery bypassRecurrent ischemic eventsHours of admissionPrevious cerebrovascular eventsRandomized clinical trialsAcute myocardial infarctionADP receptor inhibitorsLogistic regression modelingPrivate health insurance coverageHealth insurance coverageHospital bleedingHospital switchingAngiographic characteristicsArtery bypassCerebrovascular eventsContemporary US practiceCoronary Treatment